These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10025574)

  • 1. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.
    Urakami K; Mori M; Wada K; Kowa H; Takeshima T; Arai H; Sasaki H; Kanai M; Shoji M; Ikemoto K; Morimatsu M; Hikasa C; Nakashima K
    Neurosci Lett; 1999 Jan; 259(2):127-9. PubMed ID: 10025574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy.
    Urakami K; Wada K; Arai H; Sasaki H; Kanai M; Shoji M; Ishizu H; Kashihara K; Yamamoto M; Tsuchiya-Ikemoto K; Morimatsu M; Takashima H; Nakagawa M; Kurokawa K; Maruyama H; Kaseda Y; Nakamura S; Hasegawa K; Oono H; Hikasa C; Ikeda K; Yamagata K; Wakutani Y; Takeshima T; Nakashima K
    J Neurol Sci; 2001 Jan; 183(1):95-8. PubMed ID: 11166802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
    Yoshida M
    Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corticobasal degeneration and progressive supranuclear palsy--biochemical marker].
    Urakami K; Nakashima K
    Rinsho Shinkeigaku; 2002 Nov; 42(11):1162-4. PubMed ID: 12784694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
    Dickson DW
    J Neurol; 1999 Sep; 246 Suppl 2():II6-15. PubMed ID: 10525997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Yagishita S; Takamatsu J
    Neuroreport; 2001 Apr; 12(5):935-8. PubMed ID: 11303763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.
    Noguchi M; Yoshita M; Matsumoto Y; Ono K; Iwasa K; Yamada M
    J Neurol Sci; 2005 Oct; 237(1-2):61-5. PubMed ID: 15992827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Zhou X; Dickson DW
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Gentry EG; Henderson BW; Arrant AE; Gearing M; Feng Y; Riddle NC; Herskowitz JH
    J Neurosci; 2016 Jan; 36(4):1316-23. PubMed ID: 26818518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration.
    Ishizawa K; Dickson DW
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):647-57. PubMed ID: 11398841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Grassi M; Parnetti L; Agosti C; Alberici A; Premi E; Bonuccelli U; Gasparotti R; Calabresi P; Di Luca M; Padovani A
    J Alzheimers Dis; 2010; 22(1):195-203. PubMed ID: 20847421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology.
    Arai H; Morikawa Y; Higuchi M; Matsui T; Clark CM; Miura M; Machida N; Lee VM; Trojanowski JQ; Sasaki H
    Biochem Biophys Res Commun; 1997 Jul; 236(2):262-4. PubMed ID: 9240421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD.
    Robinson JL; Yan N; Caswell C; Xie SX; Suh E; Van Deerlin VM; Gibbons G; Irwin DJ; Grossman M; Lee EB; Lee VM; Miller B; Trojanowski JQ
    J Neuropathol Exp Neurol; 2020 Mar; 79(3):296-304. PubMed ID: 31999351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.
    Komori T; Arai N; Oda M; Nakayama H; Mori H; Yagishita S; Takahashi T; Amano N; Murayama S; Murakami S; Shibata N; Kobayashi M; Sasaki S; Iwata M
    Acta Neuropathol; 1998 Oct; 96(4):401-8. PubMed ID: 9797005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration.
    Wakabayashi K; Takahashi H
    Neuropathology; 2004 Mar; 24(1):79-86. PubMed ID: 15068177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.